General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash Flows from Operating Activities:        
Net loss $ (3,854) $ (6,118) $ (812) $ (7,334)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 487 475 730 431
Stock-based compensation 2,311 457 584 378
Loss on sale of property and equipment     127 0
Change in fair value of warrants 3,191 51 86 24
Non-cash interest expense     22 0
Changes in operating assets and liabilities:        
Increase in trade receivables, net 581 (115) (8,372) (5,174)
Decrease/ (increase) in prepaid expenses and other assets (1,587) 158 78 (546)
(Decrease)/ increase in trade payables 710 (753) (545) 721
Increase in employees and payroll accruals 355 1,735 1,914 1,579
Increase in accrued expenses and other liabilities 852 1,633 2,029 939
Net cash used in operating activities 3,046 (2,477) (4,159) (8,982)
Cash Flows from Investing Activities:        
Internal use software capitalization (1,049) 0    
Founders’ note receivable (459) 0    
Purchase of property and equipment (378) (799) (1,030) (1,657)
Proceeds from sale of property and equipment     6 0
Acquisitions of business, net of cash acquired (see Note 5)     0 (4,232)
Decrease/ (increase) in deposits (58) 54 76 (333)
Net cash used in investing activities (1,944) (745) (948) (6,222)
Cash Flows from Financing Activities:        
Capital contributions 0 504 504 0
Proceeds from issuance of preferred stocks, net of issuance cost     0 29,692
Proceeds from loans 0 9,025 15,516 0
Loan repayment (3,033) 0 (6,504) (6,000)
Repayment of acquisition liability (126) 0 (592) 0
Proceeds from exercise of options 882 30 78 99
Net cash provided by financing activities (2,277) 9,559 9,002 23,791
(Decrease)/ increase in cash, cash equivalents and restricted cash (1,175) 6,337 3,895 8,587
Cash, cash equivalents and restricted cash at the beginning of the year 16,092 12,197 12,197 3,610
Cash, cash equivalents and restricted cash at the end of the year 14,917 18,394 16,092 12,197
Supplemental disclosure of cash flows activities:        
Income taxes 216 221 308 208
Interest 189 171 272 328
Non-cash Investing and Financing Activities:        
Accrued acquisition liability 0 126 126 718
Accretion of preferred stocks to redemption value 52,993 3,873 7,297 2,007
Deferred offering cost included in accrued liabilities 2,406 0    
Reconciliation of cash, cash equivalents, and restricted cash reported within the statement of financial position        
Cash and cash equivalents 14,472 17,976 15,645 11,641
Restricted cash in restricted deposits 445 418    
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows $ 14,917 $ 18,394 $ 16,092 $ 12,197